Insulet news
The WiseView Research desk's stories that name Insulet, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The PODD page →
- HeadlineInsulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth
- HeadlineDaré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly
- HeadlineHere's Why Insulet (PODD) is a Strong Growth Stock
- CongressGilbert Cisneros sold $1,001 - $15,000 of PODD
- HeadlineInsulet Announces Omnipod Discover Now Available in U.S.
- CongressRo Khanna sold $1,001 - $15,000 of PODD
- CongressRo Khanna bought $1,001 - $15,000 of PODD
- CongressRo Khanna sold $1,001 - $15,000 of PODD
- CongressGilbert Cisneros bought $1,001 - $15,000 of PODD
- CongressRo Khanna bought $1,001 - $15,000 of PODD
- CongressRo Khanna bought $1,000 - $15,000 of PODD
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.